Company
Aprea Therapeutics
Aprea Therapeutics is a biopharmaceutical company focused on developing novel DDR targeted cancer therapeutics.
Also known as Aprea, Aprea Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Doylestown, Pennsylvania, United States
- Legal name
- Aprea Therapeutics, Inc.
- aprea.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in Doylestown, Pennsylvania, focused on developing and commercializing novel cancer therapeutics that target DNA damage response pathways.
Funding snapshot
- Total raised
- $3.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3.1M2025-12-10
Funding rounds
- Round, 2025
- $3.1M2025-12-10, SEC form D sold, 8 investors
Products
- Other
- APR-1051
- Web
- APR-1051
- Other
- ATRN-119
- Web
- ATRN-119
Loading relationship preview